These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26239173)

  • 41. Semiparametric regression in capture-recapture modeling.
    Gimenez O; Crainiceanu C; Barbraud C; Jenouvrier S; Morgan BJ
    Biometrics; 2006 Sep; 62(3):691-8. PubMed ID: 16984309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bayesian analysis for generalized linear models with nonignorably missing covariates.
    Huang L; Chen MH; Ibrahim JG
    Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
    Pennell ML; Whitmore GA; Ting Lee ML
    Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extending induced ROC methodology to the functional context.
    Inácio V; González-Manteiga W; Febrero-Bande M; Gude F; Alonzo TA; Cadarso-Suárez C
    Biostatistics; 2012 Sep; 13(4):594-608. PubMed ID: 22474123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating measures of diagnostic accuracy when some covariate information is missing.
    Paliwal P; Gelfand AE
    Stat Med; 2006 Sep; 25(17):2981-93. PubMed ID: 16345056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generalized linear models with coarsened covariates: a practical Bayesian approach.
    Johnson TR; Wiest MM
    Psychol Methods; 2014 Jun; 19(2):281-99. PubMed ID: 24364382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Semiparametric Bayesian joint modeling of a binary and continuous outcome with applications in toxicological risk assessment.
    Hwang BS; Pennell ML
    Stat Med; 2014 Mar; 33(7):1162-75. PubMed ID: 24123309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bayesian imputation of predictive values when covariate information is available and gold standard diagnosis is unavailable.
    Epstein LD; Muñoz A; He D
    Stat Med; 1996 Mar; 15(5):463-76. PubMed ID: 8668872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combining several screening tests: optimality of the risk score.
    McIntosh MW; Pepe MS
    Biometrics; 2002 Sep; 58(3):657-64. PubMed ID: 12230001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Semiparametric time varying coefficient model for matched case-crossover studies.
    Ortega-Villa AM; Kim I; Kim H
    Stat Med; 2017 Mar; 36(6):998-1013. PubMed ID: 27976418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy.
    Lee J; van Es N; Takada T; Klok FA; Geersing GJ; Blume J; Bossuyt PM;
    J Clin Epidemiol; 2023 Aug; 160():14-23. PubMed ID: 37295733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ROC analysis in biomarker combination with covariate adjustment.
    Liu D; Zhou XH
    Acad Radiol; 2013 Jul; 20(7):874-82. PubMed ID: 23747153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data.
    Zheng Y; Heagerty PJ
    Biostatistics; 2004 Oct; 5(4):615-32. PubMed ID: 15475423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regression analysis with missing covariate data using estimating equations.
    Zhao LP; Lipsitz S; Lew D
    Biometrics; 1996 Dec; 52(4):1165-82. PubMed ID: 8962448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bayesian approach to average power calculations for binary regression models with misclassified outcomes.
    Cheng D; Stamey JD; Branscum AJ
    Stat Med; 2009 Feb; 28(5):848-63. PubMed ID: 19061210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pattern mixture models for clinical validation of biomarkers in the presence of missing data.
    Gao F; Dong J; Zeng D; Rong A; Ibrahim JG
    Stat Med; 2017 Aug; 36(19):2994-3004. PubMed ID: 28464562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis.
    Macaskill P
    J Clin Epidemiol; 2004 Sep; 57(9):925-32. PubMed ID: 15504635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sample size calculations for ROC studies: parametric robustness and Bayesian nonparametrics.
    Cheng D; Branscum AJ; Johnson WO
    Stat Med; 2012 Jan; 31(2):131-42. PubMed ID: 22139729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.